Consulting Agreements in the Pharmaceuticals Industry

473 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (2 contracts)
Acacia Diversified Holdings, Inc. (1)
ACELRX PHARMACEUTICALS INC (1)
Acer Therapeutics Inc. (3)
ACHILLION PHARMACEUTICALS INC (1)
Aclaris Therapeutics, Inc. (7)
Acreage Holdings, Inc. (1)
ADIAL PHARMACEUTICALS, INC. (6)
Aegerion Pharmaceuticals, Inc. (6)
AEOLUS PHARMACEUTICALS, INC. (2)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (2)
AGILE THERAPEUTICS INC (1)
Akers Biosciences, Inc. (3)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (4)
ALDER BIOPHARMACEUTICALS INC (4)
ALIMERA SCIENCES INC (3)
Allergan, plc (2)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (2)
Amag Pharmaceuticals (1)
AmeriCann, Inc. (2)
Ampio Pharmaceuticals, Inc. (1)
Anacor Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (5)
Applied BioSciences Corp. (1)
APRICUS BIOSCIENCES, INC. (1)
ARADIGM CORP (2)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (1)
Artemis Therapeutics, Inc. (3)
ARVINAS, INC. (1)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (1)
Atea Pharmaceuticals, Inc. (3)
AVALON PHARMACEUTICALS INC (4)
AVENUE THERAPEUTICS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (1)
Axsome Therapeutics, Inc. (1)
Bakhu Holdings, Corp. (8)
Bespoke Extracts, Inc. (1)
Big Rock Partners Acquisition Corp. (5)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
BioPharmX Corp (2)
BODY & MIND INC. (5)
Bright Green Corp (1)
Canbiola, Inc. (7)
Cannabics Pharmaceuticals Inc. (2)
CANNAPHARMARX, INC. (2)
Cantabio Pharmaceuticals Inc. (3)
Cara Therapeutics, Inc. (1)
CASSAVA SCIENCES INC (1)
Cerecor Inc. (1)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
China Pharmaceuticals Inc (1)
China QinBa Pharmaceuticals, Inc. (1)
Clearside Biomedical, Inc. (2)
Cocrystal Pharma, Inc. (1)
CoLucid Pharmaceuticals, Inc. (2)
Context Therapeutics Inc. (5)
Corcept Therapeutics Incorporated (2)
CorMedix Inc. (1)
COSMO VENTURES INC (1)
Cure Pharmaceutical Holding Corp. (1)
Dermata Therapeutics, Inc. (2)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (1)
Elanco Animal Health Inc (1)
Eleison Pharmaceuticals Inc (6)
Elixir Pharmaceuticals, Inc. (3)
Eloxx Pharmaceuticals, Inc. (1)
ENCYSIVE PHARMACEUTICALS INC (2)
EPIX Pharmaceuticals, Inc. (1)
Eton Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (2)
Exactus, Inc. (6)
EYEGATE PHARMACEUTICALS INC (1)
EYENOVIA, INC. (2)
EyePoint Pharmaceuticals, Inc. (1)
EYETECH PHARMACEUTICALS INC (3)
Fresenius Kabi Pharmaceuticals Holding, Inc. (2)
Fulcrum Therapeutics, Inc. (2)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (1)
GRAYBUG VISION, INC. (2)
GREEN HYGIENICS HOLDINGS INC. (6)
GridIron BioNutrients, Inc. (1)
GUILFORD PHARMACEUTICALS INC (2)
HARROW HEALTH, INC. (15)
Horizon Pharma plc (2)
iANTHUS CAPITAL HOLDINGS, INC. (2)
Ikena Oncology, Inc. (1)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (1)
INSPIRE PHARMACEUTICALS INC (1)
Item 9 Labs Corp. (1)
Iterum Therapeutics plc (3)
Jiangbo Pharmaceuticals, Inc. (1)
JUNIPER PHARMACEUTICALS INC (2)
Kaya Holdings, Inc. (1)
KEMPHARM, INC (1)
KING PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Lexaria Bioscience Corp. (13)
Liquidia Technologies Inc (1)
Lumena Pharmaceuticals, Inc. (1)
MARINUS PHARMACEUTICALS INC (1)
MedMen Enterprises, Inc. (1)
MEMORY PHARMACEUTICALS CORP (2)
Menlo Therapeutics Inc. (1)
MICROCHANNEL TECHNOLOGIES CORP (2)
MiddleBrook Pharmaceuticals, Inc. (5)
Milestone Pharmaceuticals Inc. (1)
MJ Holdings, Inc. (6)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (2)
Nabriva Therapeutics plc (7)
NEKTAR THERAPEUTICS (2)
Neuralstem, Inc. (1)
NewBridge Global Ventures, Inc. (3)
NEXIEN BIOPHARMA, INC. (1)
Notis Global, Inc. (4)
NovaBay Pharmaceuticals, Inc. (5)
Novan, Inc. (1)
NUCRYST Pharmaceuticals Corp. (1)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (5)
OMEROS CORP (1)
One World Pharma, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (15)
OSI PHARMACEUTICALS INC (5)
Pacira Pharmaceuticals, Inc. (4)
Paratek Pharmaceuticals, Inc. (1)
PaxMedica, Inc. (2)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (1)
PetLife Pharmaceuticals, Inc. (2)
Pfizer (1)
Pharmagreen Biotech Inc. (1)
PHARMOS CORP (2)
Pivot Pharmaceuticals Inc. (5)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (1)
Processa Pharmaceuticals, Inc. (1)
Profile Solutions, Inc. (3)
ProPhase Labs, Inc. (1)
Pulmatrix, Inc. (2)
QUANTA INC (2)
RADIENT PHARMACEUTICALS Corp (8)
Recro Pharma, Inc. (1)
RELMADA THERAPEUTICS, INC. (6)
RespireRx Pharmaceuticals Inc. (5)
ROCK CREEK PHARMACEUTICALS, INC. (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (1)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
SIGA TECHNOLOGIES INC (2)
Sonoma Pharmaceuticals, Inc. (5)
Strongbridge Biopharma plc (1)
SUNWIN STEVIA INTERNATIONAL, INC. (4)
Supernus Pharmaceuticals, Inc. (3)
SYNERGY PHARMACEUTICALS, INC. (4)
Targeted Medical Pharma, Inc. (3)
Tarsus Pharmaceuticals, Inc. (1)
TAURIGA SCIENCES, INC. (3)
Terra Tech Corp. (2)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (1)
TFF Pharmaceuticals, Inc. (4)
The Medicines Company (6)
TherapeuticsMD, Inc. (6)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (2)
TIBET PHARMACEUTICALS, INC. (4)
Trevi Therapeutics, Inc. (1)
Tribute Pharmaceuticals Canada Inc. (2)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (1)
Vallon Pharmaceuticals, Inc. (4)
Ventyx Biosciences, Inc. (1)
VIA Pharmaceuticals, Inc. (1)
Vireo Health International, Inc. (2)
Virpax Pharmaceuticals, Inc. (1)
VIVUS INC (1)
Vyrix Pharmaceuticals, Inc. (1)
Wave Life Sciences Ltd. (1)
WEED, INC. (1)
XERIS PHARMACEUTICALS INC (1)
ZOGENIX, INC. (1)
Zomedica Pharmaceuticals Corp. (6)

Recent Contracts

Amendment to Consulting Agreement dated December 27, 2023 between Iterum Therapeutics International Limited and Dr. Michael Dunne (Iterum Therapeutics plc, Filed With SEC on March 28, 2024)
Consulting Services Agreement by and among the Company, iAnthus Capital Management, LLC and Robert Galvin dated October 11, 2023 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on March 28, 2024)
Consulting Agreement with Dr. Jay Kranzler, dated December 1, 2020 (AVENUE THERAPEUTICS, INC., Filed With SEC on March 18, 2024)
First Amendment to Consulting Agreement, by and between Registrant and Thomas Ciulla, dated as of February 17, 2024 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
Consulting Agreement dated December 18, 2023 by and between Eyepoint Pharmaceuticals, Inc. and John Landis, PhD (EyePoint Pharmaceuticals, Inc., Filed With SEC on March 8, 2024)
Amendment, dated January 8, 2024, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated April 27, 2023, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated January 8, 2024, to Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of... (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated April 27, 2023, to Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of Nadav... (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Retirement and Operating Consulting Agreement and Release with Rajiv Malik, dated October 20, 2023 (Upjohn Inc, Filed With SEC on February 28, 2024)
Consulting Agreement, dated November 20, 2023, by and between the Registrant and William J. Sandborn (Ventyx Biosciences, Inc., Filed With SEC on February 27, 2024)
Consulting Agreement, dated February 20, 2024, by and between Sergio Santillana and Ikena Oncology, Inc (Ikena Oncology, Inc., Filed With SEC on February 21, 2024)
Consulting Agreement, dated January 23, 2024, by and between Stone Blossom Capital, LLC and MedMen Enterprises Inc (MedMen Enterprises, Inc., Filed With SEC on January 30, 2024)
Consulting Agreement between the Company and Michael Moses (COSMO VENTURES INC, Filed With SEC on December 14, 2023)
Consulting Agreement between RespireRx Pharmaceuticals Inc. and Ponto Ventures LLC dated December 6, 2023 (RespireRx Pharmaceuticals Inc., Filed With SEC on December 11, 2023)
Consulting Agreement, by and between Theseus Pharmaceuticals, Inc. and David Kerstein, M.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
Consulting Agreement, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson, Ph.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
First Amendment to the Consulting Agreement, dated September 20, 2023, by and between Goodness Growth Holdings, Inc. and Grown Rogue Unlimited, LLC (Vireo Health International, Inc., Filed With SEC on November 14, 2023)
Form of Consulting Agreement (Exactus, Inc., Filed With SEC on October 5, 2023)
Consulting Agreement, dated May 24, 2023, by and between Goodness Growth Holdings, Inc. and Grown Rogue Unlimited ULC (Vireo Health International, Inc., Filed With SEC on August 4, 2023)
Consulting Agreement by and between 4Front Ventures Corp. and Maha Consulting LLC, effective as of July 24, 2023 (4Front Ventures Corp., Filed With SEC on July 28, 2023)
Consulting Agreement, by and between the Company and Jerome Dvonch Consulting, LLC, effective August 15, 2023 (Sonoma Pharmaceuticals, Inc., Filed With SEC on July 14, 2023)
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and J. Christopher Naftzger (Nabriva Therapeutics plc, Filed With SEC on July 7, 2023)
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Daniel Dolan (Nabriva Therapeutics plc, Filed With SEC on July 7, 2023)
Consulting Agreement, dated June 8, 2023, between OptiNose (OptiNose, Inc., Filed With SEC on June 13, 2023)
CONSULTING AGREEMENT (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on May 25, 2023)
Consulting agreement, dated April 22, 2023, by and between Registrant and Esther Rajavelu (Fulcrum Therapeutics, Inc., Filed With SEC on May 15, 2023)
Consulting Agreement between Nektar Therapeutics and FLG Partners, LLC dated April 7, 2023 (NEKTAR THERAPEUTICS, Filed With SEC on May 10, 2023)
Consulting Agreement between the Company and Carbek, LLC (MJ Holdings, Inc., Filed With SEC on May 5, 2023)
Consulting Agreement, by and between GRI Bio, Inc. and Albert Agro, M.D., dated as of January 9, 2023 (Vallon Pharmaceuticals, Inc., Filed With SEC on April 21, 2023)
Consulting Agreement, by and between Nabriva Therapeutics US, Inc. and Christine Guico-Pabia (Nabriva Therapeutics plc, Filed With SEC on April 17, 2023)
Consulting Agreement, by and between the Company and Jerome Dvonch, dated April 7, 2023 (Sonoma Pharmaceuticals, Inc., Filed With SEC on April 13, 2023)
Amendment to Consulting Agreement, dated March 29, 2023, by and between the Company and Dr. Jonathan Javitt (Big Rock Partners Acquisition Corp., Filed With SEC on March 31, 2023)
Consulting Agreement between the Company and Andrew Jones, dated February 15, 2023 (NovaBay Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
First Amendment to Consulting Agreement with Spartan Capital Securities, LLC (Processa Pharmaceuticals, Inc., Filed With SEC on March 30, 2023)
Consulting Agreement, between the Company and Francis Plat (Milestone Pharmaceuticals Inc., Filed With SEC on March 29, 2023)
Amendment No. 1 to Consulting Services Agreement, dated as of March 23, 2023, by and between the Company and Frank Ruffo (Aclaris Therapeutics, Inc., Filed With SEC on March 27, 2023)
Consulting Agreement by and between the Registrant and Dr. Jeffrey Heier, dated as of October 17, 2022 (OCULAR THERAPEUTIX, INC, Filed With SEC on March 6, 2023)
Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of Nadav Kidron (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2023)
General Consulting and Services Agreement by and between TherapeuticsMD, Inc. and MCD Consulting Management Services, LLC, dated February 21, 2023 (TherapeuticsMD, Inc., Filed With SEC on February 27, 2023)